Cognitive and psychological recovery patterns across different care pathways 12 months after hospitalization for COVID-19: A multicenter cohort study (CO-FLOW)

被引:4
|
作者
Bek, L. Martine [5 ]
Hellemons, Merel E. [1 ]
Berentschot, Julia C. [1 ]
Visser, Marieke M. [2 ]
Huijts, Susanne M. [1 ]
van Bommel, Jasper [3 ,4 ]
van Genderen, Michel E. [3 ,4 ]
Aerts, Joachim G. J., V [1 ]
Ribbers, Gerard M. [2 ]
van den Berg-Emons, Rita J. G.
Heijenbrok-Kal, Majanka H. [2 ]
CO FLOW collaboration Grp
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med, Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Resp Med, Rotterdam, Netherlands
[3] Rijndam Rehabil, Rotterdam, Netherlands
[4] Univ Med Ctr Rotterdam, Erasmus MC, Dept Adult Intens Care Med, Rotterdam, Netherlands
[5] Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med, Dr Molewaterplein 40, Rotterdam NL-3015 ADQ, Netherlands
关键词
COVID-19; Rehabilitation; Cognition; Depression; Anxiety; PTSD; STRESS; QUESTIONNAIRE; VALIDATION; FAILURES; DISORDER; SCALE;
D O I
10.1016/j.rehab.2023.101737
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background: The comparison of recovery patterns for different care pathways following COVID-19 is necessary for optimizing rehabilitation strategies. Objectives: To evaluate cognitive and psychological outcomes across different care pathways up to 12 months after hospitalization for COVID-19.Methods: CO-FLOW is an ongoing multicenter prospective cohort study with assessments at 3, 6, and 12 months after hospitalization for COVID-19. The main outcomes are cognitive deficits (Montreal Cognitive Assessment, score <26), cognitive failure (Cognitive Failure Questionnaire, score >43), posttraumatic stress disorder (PTSD; Impact of Event Scale-Revised, score >= 33), and anxiety and depression (Hospital Anxiety and Depression Scale, subscale score >= 11).Results: In total, data from 617 participants were analyzed. Mean age was 59.7 (SD 11.4) years and 188 (31%) were female. Significant recovery occurred within the first 6 months post-discharge (p <= 0.001). Cognitive deficits persisted in 21% (101/474), and psychological problems in 15% (74/482) of people at 12 months. Significantly improved cognition scores were reported for people who did not receive rehabilitation ('No-rehab'; 124/617, 20%; mean difference, MD 2.32, 95% CI 1.47 to 3.17; p<0.001), those who received community-based rehabilitation ('Com-rehab'; 327/617, 53%; MD 1.27, 95% CI 0.77 to 1.78; p<0.001), and those who received medical rehabilitation ('Med-rehab'; 86/617, 14%; MD 1.63, 95% CI 0.17 to 3.10; p = 0.029). Med-rehab participants experienced more cognitive failure from 3 to 6 months (MD 4.24, 95% 1.63 to 6.84; p = 0.001). Com-rehab showed recovery for PTSD (MD -2.43, 95% -3.50 to -1.37; p<0.001), anxiety (MD -0.67, 95% -1.02 to -0.32; p<0.001), and depression (MD -0.60, 95% -0.96 to -0.25; p<0.001), but symptoms persisted at 12 months.Conclusions: Survivors of COVID-19 showed cognitive and psychological recovery, especially within the first 6 months after hospitalization. Most persistent problems were related to cognitive functioning at 12 months. Recovery differed rehabilitation settings. Additional cognitive or psychological support might be warranted in people who medical or community-based rehabilitation.(c) 2023 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Post-COVID-19 condition symptoms 12 and 24 months after COVID-19 during the first month of the pandemic in Melbourne: a cohort study
    Ling, Dorothy Q.
    Gibney, Grace
    James, Fiona
    Holmes, Natasha E.
    Chua, Kyra Y. L.
    MEDICAL JOURNAL OF AUSTRALIA, 2024, 220 (06) : 336 - 338
  • [32] Requirements for Home Oxygen After Hospitalization for COVID-19 in 2020 and 2021: Results From the US Oxford Multicenter Retrospective Cohort Study
    Freedman, M. B.
    Kim, Y.
    Ziauddin, L.
    Delisa, J. A.
    Adegunsoye, A. O.
    Alvi, S.
    Christian, C.
    Chung, Y.
    Gardner, J. M.
    Gordon, H. S.
    Greenberg, J. A.
    Harnois, L. J.
    Jain, B.
    Karnik, R.
    Kaul, M.
    Kaur, R.
    Keating, L.
    Khouzam, N.
    Labedz, S. L.
    Mokhlesi, B.
    Pinney, S.
    Rintz, J.
    Rubinstein, I.
    Taylor, A.
    Tehrani, S.
    Vines, D. L.
    Gerald, L. B.
    Krishnan, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] Health-related quality of life after surviving intensive care for COVID-19: a prospective multicenter cohort study
    Halvorsen, Peter
    Hultstroem, Michael
    Haestbacka, Johanna
    Larsson, Ing-Marie
    Eklund, Rakel
    Arnberg, Filip K.
    Hokkanen, Laura
    Frithiof, Robert
    Wallin, Ewa
    Orwelius, Lotti
    Lipcsey, Miklos
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [34] Health-related quality of life after surviving intensive care for COVID-19: a prospective multicenter cohort study
    Peter Halvorsen
    Michael Hultström
    Johanna Hästbacka
    Ing-Marie Larsson
    Rakel Eklund
    Filip K. Arnberg
    Laura Hokkanen
    Robert Frithiof
    Ewa Wallin
    Lotti Orwelius
    Miklós Lipcsey
    Scientific Reports, 13
  • [35] Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
    Rocha, Roseany Patricia Silva
    de Souza Andrade, Amanda Cristina
    Melanda, Francine Nesello
    Muraro, Ana Paula
    CADERNOS DE SAUDE PUBLICA, 2024, 40 (02):
  • [36] Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study
    Gharibzadeh, Safoora
    Routen, Ash
    Razieh, Cameron
    Zaccardi, Francesco
    Lawson, Claire
    Gillies, Clare
    Heller, Simon
    Davies, Melanie
    Atkins, Helen
    Bain, Stephen C.
    Lone, Nazir L.
    Poinasamy, Krisnah
    Peto, Tunde
    Robertson, Elizabeth
    Young, Bob
    Johnston, Desmond
    Quint, Jennifer
    Valabhji, Jonathan
    Ismail, Khalida
    Marks, Michael
    Horsley, Alex
    Docherty, Annemarie
    Harrison, Ewen
    Chalmers, James
    Ho, Ling-Pei
    Raman, Betty
    Brightling, Chris
    Elneima, Omer
    Evans, Rachel
    Greening, Neil
    Harris, Victoria C.
    Houchen-Wolloff, Linzy
    Sereno, Marco
    Shikotra, Aarti
    Singapuri, Amisha
    Wain, Louise
    Langenberg, Claudia
    Dennis, John
    Petrie, John
    Sattar, Naveed
    Leavy, Olivia
    Richardson, Mattew
    Saunders, Ruth M.
    Mcardle, Anne
    Mcasuley, Hamish
    Yates, Tom
    Khunti, Kamlesh
    ECLINICALMEDICINE, 2025, 79
  • [37] The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China
    Zhao, Yimiao
    Shi, Le
    Jiang, Zhendong
    Zeng, Na
    Mei, Huan
    Lu, Yu
    Yang, Jinfeng
    Jin, Fenshu
    Ni, Shuyu
    Wu, Shuilin
    Su, Sizhen
    Zheng, Yongbo
    Yuan, Kai
    Yan, Wei
    Sun, Siwei
    Meng, Shiqiu
    Sun, Jie
    Khan, Zunera
    Aarsland, Dag
    Shi, Jie
    Li, Xiangyou
    Bao, Yanping
    Lu, Lin
    MOLECULAR PSYCHIATRY, 2023, 28 (04) : 1793 - 1801
  • [38] A prospective cohort study on cognitive and psychological outcomes in COVID-19 ICU survivors at 3 months of follow up (vol 11, 1288761, 2024)
    Thomas, Merlin
    Hameed, Mansoor
    Hussein, Mousa
    George, Saibu
    Rajalekshmi, M. R.
    Akram, Jaweria
    Sharma, Rohit
    Al Adab, Aisha Hussain O.
    Ahmad, Mushtaq
    Singh, Rajvir
    Raza, Tasleem
    FRONTIERS IN MEDICINE, 2025, 12
  • [39] The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China
    Yimiao Zhao
    Le Shi
    Zhendong Jiang
    Na Zeng
    Huan Mei
    Yu Lu
    Jinfeng Yang
    Fenshu Jin
    Shuyu Ni
    Shuilin Wu
    Sizhen Su
    Yongbo Zheng
    Kai Yuan
    Wei Yan
    Siwei Sun
    Shiqiu Meng
    Jie Sun
    Zunera Khan
    Dag Aarsland
    Jie Shi
    Xiangyou Li
    Yanping Bao
    Lin Lu
    Molecular Psychiatry, 2023, 28 : 1793 - 1801
  • [40] Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study
    Maria Jimenez-Rodriguez, Beatriz
    Maria Trivino-Ibanez, Eva
    Gutierrez-Fernandez, Jose
    Dolores Romero-Ortiz, Ana
    Maria Ramos-Urbina, Eldis
    Morales-Garcia, Concepcion
    HEALTHCARE, 2022, 10 (12)